Figure 9.

A Synthetic route for the fabrication of DOX/MnO₂@PVCL NGs. B Schematic illustration of the utilization of DOX/MnO₂@PVCL NGs for UTMD-promoted delivery of NGs for MRI-guided cancer chemotherapy. C DOX release profile from DOX/MnO2@PVCL NGs at pH = 7.4 or 6.5 in the presence or absence of GSH (10 mM). D Tumour growth curves after different treatments (n = 5). Tumour volumes were normalized to their initial values. Adapted with permission from ¹⁴⁸, copyright 2020 Ivyspring International Publisher.